Contraception
RSSArticles
-
Expanding Intrauterine Contraceptive Choices: Science Seeks Options
The copper T 380A intrauterine device (IUD), developed almost 50 years ago, was introduced in the United States in 1988. It is an extremely effective form of birth control. Researchers are conducting a clinical trial comparing the device with a newer, smaller copper IUD not sold in the United States.
-
Long-Lasting, Woman-Controlled Contraception Is Here
Annovera is designed for 21 days of continuous use, followed by a seven-day ring-free interval, during which the ring is removed, washed, and stored. Unlike other products, the same ring is used for subsequent cycles for an entire year (13 cycles total).
-
More Young Adults Receiving HPV Vaccination, but There Is Room for Improvement
Results of a new report indicate that the percentage of adults ages 18-26 years who received one or more doses of human papillomavirus (HPV) vaccine nearly doubled between 2013 and 2018. The percentage of adults in the same age category who received the recommended number of doses of HPV vaccine increased from 13.8% to 21.5%.
-
New Congressional Funding for STD Programs: Is It Enough?
Congress recently increased federal funding for sexually transmitted disease (STD) prevention for the first time since 2003, with a $3.51 million addition in base funding to the CDC’s STD prevention programs. But is the funding enough to fully address the rise in national STD rates?
-
Consensus Position Statement on the Use of Testosterone in Women
Clinicians lack clearly established guidance and indications for testosterone therapy for women, which has led to considerable variation in practice patterns. The absence of clear indications and approved products for women has resulted in the use of compounded therapies or off-label prescription of testosterone formulations approved for men.
-
Check Your Practice: Are Unnecessary Pelvic Exams and Pap Tests Being Performed?
While pelvic examinations and cervical cancer screenings are no longer recommended for most young women under age 21 years during routine health visits, results from a new national study indicate that millions of women are undergoing these tests unnecessarily.
-
Research Examines Effect of Pregnancy Preferences on Contraceptive Use
Researchers found that women with a strong preference to avoid pregnancy were far more likely to use any contraceptive method. However, more than 50% of women who reported a low preference to avoid pregnancy used some form of birth control.
-
Postpartum LARC: Highly Effective, but Restricted by Some Hospitals
Women who receive care in Catholic facilities may be denied postpartum LARC due to religious directives that ban such care. In 10 states, more than 30% of all hospital beds are in Catholic facilities. In about 50% of states, more than one in five hospital beds is in a Catholic facility.
-
Help Women Take Charge of Breast Cancer Risks
About one in three breast cancer cases could be prevented by lifestyle modifications such as weight management, exercise, diet, and alcohol consumption, according to a recent presentation at the North American Menopause Society 2019 Annual Meeting.
-
Progesterone After Mifepristone to Halt Medication Abortion: Is It Safe?
Results of a new study indicated that women who initiate medication abortion but opt to stop in the middle of treatment may be at risk for serious blood loss.